Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Date:2/21/2013

2931 and LX7101 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.Lexicon Pharmaceuticals, Inc.
Selected Financial Data

 Consolidated Statements of Operations DataThree Months EndedDecember 31,Year EndedDecember 31,(In thousands, except per share data)2012201120122011(unaudited)  (unaudited)Revenues:Collaborative research

$
218$
320$
783$
,632Subscription and license fees

-23306217Total revenues

2183431,0891,849Operating expenses:Research and development, including stock-based compensation

of $798, $769, $3,673 and $3,249, respectively

20,99028,10782,57491,828Increase (decrease) in fair value of Symphony Icon, Inc
purchase liability

(200)1,5689,8876,766General and administrative, including stock-based compensation

of $792, $584, $2,822 and $2,458, respectively

3,9204,01017,04317,350Total operating expenses

24,71033,685109,504115,944Loss from operations

(24,492)(33,342)(108,415)(114,095)Interest income

5540213255I
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lexicon To Present At The BIO CEO & Investor Conference
2. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
3. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
4. Lexicon to Provide Third Quarter 2012 Financial Results
5. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
6. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
7. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
8. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
9. Lexicon to Provide Second Quarter 2012 Financial Results
10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
11. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 A study on ... recently added to Transparency Market Research,s database of market ... Analysis, Size, Share & Forecast (2011 - 2017)", the ... US$ 3.9 billion in 2011, would observe growth at ... period of the report), and end-up valuing US$ 4.8 ...
(Date:9/22/2014)... Children,s National Health System has announced ... 5 p.m. EDT for its "Make Your Medical ... continued strong interest from inventors.  Two ... to the winning presentations at the Sheikh Zayed Institute ... Children,s National in October. For competition details,  click ...
(Date:9/22/2014)... 2014 Research and Markets has ... Novel Hypercholesterolemia Drugs" report to their offering. ... high cholesterol burden despite the presence of many cholesterol-lowering ... options, statins have been ubiquitously prescribed over the last ... LDL cholesterol (LDLC) is the cornerstone of assessing heart ...
Breaking Medicine Technology:Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 2Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 3Global Magnetic Resonance Imaging (MRI) Market Worth US $4.8 Billion by 2017: Transparency Market Research 4Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3
... One out of three U.S. adults plan to skip ... Medical telephone poll. Against that backdrop, two top clinical leaders ... American public that influenza season can be a deadly time ... asthma or COPD (Chronic Obstructive Pulmonary Disease). Such patients need ...
... One week after a CDC report outlined the devastating ... which causes 8,000 U.S. deaths and costs billions of ... of patients, families, advocates, physicians and scientists, last night ... discoveries and unique contributions to the field of dermatology ...
Cached Medicine Technology:Poll: One Out of Three U.S. Adults Not Planning to Get Flu Shot This Year 2American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville 2American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville 3
(Date:9/22/2014)... 2014 (HealthDay News) -- Metformin, a drug commonly used ... levels of thyroid-stimulating hormone (TSH) among patients with an ... cautioned that low TSH levels may be associated with ... was not established in this study. Among those ... were 495 incidences of low levels of thyroid-stimulating hormone ...
(Date:9/22/2014)... September 22, 2014 The report ... application, end user, and geography. The equipment segment ... physiotherapy equipment market, by product. However, the accessories ... CAGR in the forecast period, owing to the ... Electric stimulation and ultrasound segments are the fastest-growing ...
(Date:9/22/2014)... In a big step for securing critical information ... Dartmouth College researchers have created a new approach ... they are using a terminal and automatically logs ... else steps in to use their terminal. , ... researchers recently presented their findings at ...
(Date:9/22/2014)... September 22, 2014 Don Allred Insurance is ... office in Burlington, NC. The satellite office, located in the ... on October 15, 2014, and offer all of the same ... Street. , Allred Insurance spokesperson Scott Allred cites an expanding ... availability as two of the major factors driving the decision ...
(Date:9/22/2014)... The report covers the Europe ... and energy devices market revenue and volume for ... Devices, Non-Invasive Body Contouring (NIBC) Devices and Laser ... shares by revenue for the above mentioned countries ...     Information on market size for the three ...
Breaking Medicine News(10 mins):Health News:Diabetes Drug Metformin May Affect Thyroid in Some Patients 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Dartmouth's new ZEBRA bracelet strengthens computer security 2Health News:Dartmouth's new ZEBRA bracelet strengthens computer security 3Health News:Allred Insurance to Open New Burlington Branch Office 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 2Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 3Health News:Europe Aesthetic Lasers and Energy Devices Market Analysis for 2006-2020 in New Research Report at LifeScienceIndustryResearch.com 4
... has decided to include Genentech's breast cancer drug, Herceptin ... drug will now be subsidized throughout Australia. ... Australian women would be eligible to start using the ... the government about A$470 million ($356 million) by 2009. ...
... Since the start of the one child family policy in ... decreased, and a gross imbalance in the sex ratio// has ... ,The one child family policy has been in force in ... measure. To examine the impact of this policy, researchers analysed ...
... the Royal Adelaide Hospital may have found a cheap, ... aged care from becoming vitamin D deficient.// ... in the latest edition of the Medical Journal of ... Cleland, Clinical Professor at the Department of Medicine, University ...
... President of the Canadian Medical Association (CMA) said that Canadian ... health of their own children// although in general they rated ... to a survey carried out by Ipsos-Reid, commissioned by the ... kids aged 2-17 are obese/overweight, however only 9% of Canadian ...
... new warnings about the risk of psychotic behavior, heart ... on Monday. ,These drugs include Novartis ... Administration spokeswoman, Susan Bro said. ,She ... pressure. They must also include warnings about the risk ...
... shot on his family’s farm near Stowmarket Suffolk, has caused ... rabbit flu.// ,John Freeman, 29, had become infected ... a rabbit on his farm. His mother explained that he ... after three days. ,It was revealed by the ...
Cached Medicine News:Health News:Lower Birth Rate and Fewer Girls under China’s one Child Polic 2Health News:Improving Vitamin D Levels in Aged Care Residents 2Health News:New Alerts Needed for ADHD drugs 2
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
... an electrical power supply, MERKUR offers a broad ... a gas spring for ease of operation. For ... a foot pedal hydraulic system. Thanks to its ... anytime in a highly mobile and flexible manner. ...
... table MARS Enduro is the ideal ... are required before, during or directly ... motorised longitudinal adjustment and the filigreed ... conditions in examination, induction and operating ...
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
Medicine Products: